ArticleFrontiers in pharmacology2022

Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study.

Yihan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.